Meghan Eileen Brown, OTR | |
402 W 1st St, Adrian, MO 64720-9277 | |
(816) 297-2107 | |
Not Available |
Full Name | Meghan Eileen Brown |
---|---|
Gender | Female |
Speciality | Occupational Therapist - Physical Rehabilitation |
Location | 402 W 1st St, Adrian, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659849511 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XP0019X | Occupational Therapist - Physical Rehabilitation | 004184 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Meghan Eileen Brown, OTR 14104 Mohawk Rd, Leawood, KS 66224-1123 Ph: (913) 837-7223 | Meghan Eileen Brown, OTR 402 W 1st St, Adrian, MO 64720-9277 Ph: (816) 297-2107 |
News Archive
The GW Cancer Institute (GWCI) was recently awarded a $2.4 million grant from the D.C. Cancer Consortium to establish and coordinate a City-wide Patient Navigation Network (CPNN) in Washington, D.C.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today extended the Grants ManagerĀ® web-based budgeting application with a new Contracting module, enabling sites and sponsors to negotiate clinical trial site budgets directly online, eliminating the burden of managing hundreds of email messages and reducing budgeting cycle times.
Repligen Corporation announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering a recombinant form of Protein A which is identical in structure to the commercial form of Protein A from Staphylococcus aureus which is used in the production of many of the world's approved monoclonal antibodies. The patent, which will remain in force until 2028, covers a new Repligen proprietary product which is now available in commercial quantities.
Preventing HIV in sex workers is a powerful tool in lowering the worldwide burden of the disease, and a new study could help ensure that high-risk women take advantage of medical safeguards.
› Verified 9 days ago